Award Timing Predetermined Award Timing Predetermined [Flag] Microchips Biotech, Inc. Microchips Biotech, Inc. [Member] Microchips Biotech, Inc. [Member] Entity File Number Entity File Number Additional Paid-in Capital Additional Paid-in Capital [Member] Going Concern Liquidity [Policy Text Block] Liquidity Tabular List, Table Tabular List [Table Text Block] Recently Adopted Accounting Pronouncements/Recently Issued Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Other indirect costs Other Indirect Costs [Member] Other Indirect Costs Reverse stock split adjustment (in shares) Stock Issued During Period, Shares, Reverse Stock Splits Royalty payments Payments for Royalties Sale Of Future Royalties Sale Of Future Royalties [Member] Sale Of Future Royalties Research and development credit Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount License fee revenue and other revenue License [Member] Measurement Basis [Axis] Measurement Basis [Axis] Adjustment to Compensation: Adjustment to Compensation [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Cumulative total received from grants Cumulative Total Received From Grants Cumulative Total Received From Grants Other current assets Other Assets, Miscellaneous, Current Amended and Restated 2014 Stock Incentive Plan Amended And Restated Two Thousand Fourteen Stock Incentive Plan [Member] Amended And Restated Two Thousand Fourteen Stock Incentive Plan [Member] Milestone payments, contingent amount Milestone Payments, Contingent Amount Milestone payments, contingent amount. Weighted- Average Remaining Contractual Life (Years) Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term Roll Forward Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual term roll forward. Stock compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Stock, Class of Stock [Table] Stock, Class of Stock [Table] Pear Tree Pharmaceuticals, Inc. Pear Tree Pharmaceuticals, Inc. [Member] Pear Tree Pharmaceuticals, Inc. Adjustment to Compensation, Amount Adjustment to Compensation Amount Concentration risk percentage Concentration Risk, Percentage December 2023 Warrants December 2023 Warrants [Member] December 2023 Warrants Principles of Consolidation Consolidation, Policy [Policy Text Block] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Stock Options Share-Based Payment Arrangement, Option [Member] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Percent Effective Income Tax Rate Reconciliation, Percent [Abstract] Total stockholders' equity (deficit) Beginning balance Ending balance Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Schedule of Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Issuance of common stock, net of issuance costs (in shares) Stock Issued During Period, Shares, New Issues Grant, DARE-PTB1 Grant, DARE-PTB1 [Member] Grant, DARE-PTB1 Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Interest rate on insurance financing Insurance Financing, Interest Rate Insurance Financing, Interest Rate Liabilities and stockholders’ equity (deficit) Liabilities and Equity [Abstract] State State and Local Jurisdiction [Member] Cover [Abstract] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Maximum Maximum [Member] Options exercisable, ending (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Amount reserved for issuance (in shares) Convertible Preferred Stock, Shares Reserved for Future Issuance Officers' compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Bonus Plan, Percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Bonus Plan, Percent Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Vendor Concentration Concentration Risk Disclosure [Text Block] Deferred offering costs Deferred Costs Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Vendor Three Major Vendor Three [Member] Major Vendor Three Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Loss before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Underlying Awards Granted Under the Amended Two Thousand Fourteen Plan Underlying Awards Granted Under the Amended Two Thousand Fourteen Plan [Member] Underlying Awards Granted Under the Amended Two Thousand Fourteen Plan Amount awarded for grant Proceeds From Award Of Grants Proceeds From Award Of Grants Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Research and development funding percentage Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred, For General And Administrative Expenses, Percentage Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred, For General And Administrative Expenses, Percentage Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Finance lease, incremental borrowing rate, prime rate Finance Lease, Incremental Borrowing Rate, Prime Rate Finance Lease, Incremental Borrowing Rate, Prime Rate Current portion of lease liabilities (operating) Operating Lease, Liability, Current Document Fiscal Period Focus Document Fiscal Period Focus Royalty Interest Financing Royalty Interest Financing [Text Block] Royalty Interest Financing Award Timing Method Award Timing Method [Text Block] Preferred stock trigger price (in usd per share) Preferred Stock, Convertible, Share Price Trigger Preferred Stock, Convertible, Share Price Trigger Warrants Warrants, Policy [Policy Text Block] Warrants, Policy Award Type [Axis] Award Type [Axis] Deferred revenue, non-current Contract with Customer, Liability, Noncurrent Payment to be received upon termination without cause Employment Agreement, Salary Payment Received Upon Termination Without Cause Employment Agreement, Salary Payment Received Upon Termination Without Cause Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Sales Milestones Sales Milestones [Member] Sales Milestones [Member] Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Trading Symbol Trading Symbol Payment to be received upon termination for cause or for good reason Employment Agreement, Salary Payment Received Upon Termination for Cause or Good Reason Employment Agreement, Salary Payment Received Upon Termination for Cause or Good Reason Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Changes in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Total payment Research and Development Agreement, Commitment, Amount Research and Development Agreement, Commitment, Amount Entity Address, City or Town Entity Address, City or Town Weighted-average discount rate, Finance leases Finance Lease, Weighted Average Discount Rate, Percent Beneficial ownership percentage Beneficial Ownership Percentage Beneficial Ownership Percentage Effect of exchange rate changes on cash and cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Deferred tax assets, net of valuation allowance Deferred Tax Assets, Net of Valuation Allowance Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Statement of Income Location, Balance [Domain] Statement of Income Location, Balance [Domain] Foundation Foundation [Member] Foundation Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Class of warrant or right, extent holder own percentage Class of Warrant or Right, Extent Holder Own Percentage Class of Warrant or Right, Extent Holder Own Percentage Decreases related to settlements with taxing authorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Entity Emerging Growth Company Entity Emerging Growth Company Weighted-average remaining lease term, Finance leases (in years) Finance Lease, Weighted Average Remaining Lease Term Stock options outstanding (in shares) Outstanding beginning balance (in shares) Outstanding ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Debt issuance cost Debt Issuance Costs, Net CRADA CRADA [Member] CRADA Less: amount representing interest Finance Lease, Liability, Undiscounted Excess Amount Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Number of consecutive trading days Preferred Stock, Convertible, Threshold Consecutive Trading Days Preferred Stock, Convertible, Threshold Consecutive Trading Days Upon Achieving Certain Clinical And Regulatory Development Milestones Upon Achieving Certain Clinical And Regulatory Development Milestones [Member] Upon Achieving Certain Clinical And Regulatory Development Milestones [Member] Deferred tax assets, increase in valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Authorized amount (up to) Sale Of Stock, Authorized, Amount Sale Of Stock, Authorized, Amount Vendor Five Major Vendor Five [Member] Major Vendor Five Number of additional payment Royalty Agreement, Number Of Additional Payments Royalty Agreement, Number Of Additional Payments Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Income tax provision Total (benefit) provision Income Tax Expense (Benefit) Proceeds from sale of royalty and milestone rights Proceeds From Sale Of Royalty And Milestone Rights Proceeds From Sale Of Royalty And Milestone Rights Advanced written notice period Upfront License Fee, Advanced Written Notice, Period Upfront License Fee, Advanced Written Notice, Period Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Personnel-related (including stock compensation) Personnel-Related (Including Stock Compensation) [Member] Personnel-Related (Including Stock Compensation) Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Property and equipment, gross Property, Plant and Equipment, Gross Transaction costs Sale Of Royalty And Milestone Rights, Net Of Transaction Costs Sale Of Royalty And Milestone Rights, Net Of Transaction Costs Other current assets Increase (Decrease) in Other Current Assets Defined contribution plan, employer matching contributions Defined Contribution Plan, Employer Discretionary Contribution Amount Reverse Stock Split Stockholders' Equity, Policy [Policy Text Block] Other income (expense) Other Income and Expenses [Abstract] Digital offering Sale Of Stock, Reimbursed And Reimbursable Issuance Costs Sale Of Stock, Reimbursed And Reimbursable Issuance Costs Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Health insurance premium Health Insurance Premiums, Monthly Amount Health Insurance Premiums, Monthly Amount All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Options vested and expected to vest, ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Accrued expenses Accrued Liabilities, Current Other Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Net cash (used in) provided by operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Effective Income Tax Rate Reconciliation [Table] Effective Income Tax Rate Reconciliation [Table] Property and equipment, useful life Property, Plant and Equipment, Useful Life Preferred stock, par value (in usd per share) Preferred Stock, Par or Stated Value Per Share Subsequent Event Subsequent Event [Member] Schedule of Assumptions Used in Black-Scholes Option-Pricing Model for Stock Options Granted to Employees, and Non-Employee Directors Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Other development programs Other Development Programs [Member] Other Development Programs Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Depreciation and amortization Depreciation Accrued indemnification provisions Accrued Indemnification Provisions Accrued indemnification provisions. Research and development expense credit Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount Options vested and expected to vest, ending (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Non-dilutive grant funding, percentage excluded Non-Dilutive Grant Funding, Percentage Excluded Non-Dilutive Grant Funding, Percentage Excluded Non-cash interest expense Non-Cash Interest Expense On Liability Related To Sale Of Future Royalties Non-Cash Interest Expense On Liability Related To Sale Of Future Royalties Equity Components Equity Components [Axis] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Other advanced clinical stage programs Other Advanced Clinical Stage Programs [Member] Other Advanced Clinical Stage Programs Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Number of reportable segments Number of Reportable Segments Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Merger Agreement Merger Agreement [Member] Merger Agreement Entity Address, State or Province Entity Address, State or Province Principal payments on finance lease Financing cash flows from finance lease Finance Lease, Principal Payments Additions to property and equipment and reduction of deposits Additions To Property And Equipment Included In Accrued Expenses And Accounts Payable Additions To Property And Equipment Included In Accrued Expenses And Accounts Payable Total current liabilities Liabilities, Current Commitments And Contingencies [Line Items] Commitments And Contingencies [Line Items] Commitments and contingencies. Individual: Individual [Axis] Other receivables Increase (Decrease) in Other Receivables Income Tax Jurisdiction [Domain] Income Tax Jurisdiction [Domain] Finance right-of-use assets obtained in exchange for new finance lease liabilities Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Document Annual Report Document Annual Report Research and development Research and Development Expense [Member] Research and Development Arrangement, Contract to Perform for Others, Type Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Major Vendor Major Vendor [Member] Major Vendor Project [Domain] Project [Domain] Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Repayment of liability on sale of future royalties Repayment Of Liability On Sale Future Royalties Repayment Of Liability On Sale Future Royalties Entity Interactive Data Current Entity Interactive Data Current Total lease payments Operating And Finance Lease Liability Payments Due Operating And Finance Lease Liability Payments Due Supplemental investment (in shares) Class Of Warrant Or Right, Supplement Investment Share Amount Class Of Warrant Or Right, Supplement Investment Share Amount 2014 Employee Stock Purchase Plan Two Thousand And Fourteen Employee Stock Purchase Plan [Member] Two thousand and fourteen employee stock purchase plan. Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Options exercisable, ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Stock compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount 2027 Operating And Finance Lease Liability Payments Due Year Two Operating And Finance Lease Liability Payments Due Year Two Business Combination, Contingent Consideration, Type [Axis] Business Combination, Contingent Consideration, Type [Axis] Convertible preferred stock, shares issued upon conversion (in shares) Convertible Preferred Stock, Shares Issued upon Conversion Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Insurance Financing Insurance Financing [Member] Insurance Financing Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Amortized weighted average period Weighted Average Amortization Period Weighted Average Amortization Period 2027 Finance Lease, Liability, to be Paid, Year Two Other non-current assets Other Assets, Noncurrent Customer [Domain] Customer [Domain] Entity Central Index Key Entity Central Index Key PEO Name PEO Name Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Direct program costs: Research And Development Direct Program Costs [Abstract] Research And Development Direct Program Costs Research and development: Research and Development Expense [Abstract] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Digital Offering Digital Offering, LLC [Member] Digital Offering, LLC Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Exercise price (in usd per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Vendor Two Major Vendor Two [Member] Major Vendor Two Milestone payments Research And Development, Milestone Payment Research and development milestone payment. Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Class of Stock [Domain] Class of Stock [Domain] Income taxes (benefit) at statutory rates Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Deferred grant funding Deferred Grant Funding, Current Deferred Grant Funding, Current Subsequent Event Type [Axis] Subsequent Event Type [Axis] Indirect costs: Research And Development Expense, Indirect Costs Research And Development Expense, Indirect Costs Significant Accounting Policies [Line Items] Significant Accounting Policies [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Proceeds from royalties received Upfront payment from the sale of future royalties Proceeds from Royalties Received Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Research and development Research and Development Expense Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Schedule of Changes in the Liability Related to the Royalty Interest Financing Schedule Of Changes In The Liability Related To The Royalty Interest Financing [Table Text Block] Schedule Of Changes In The Liability Related To The Royalty Interest Financing Deferred Offering Costs Deferred Charges, Policy [Policy Text Block] Fair Value as of Grant Date Award Grant Date Fair Value Net operating loss carryforwards Operating Loss Carryforwards Changes in unrecognized tax benefits Effective Income Tax Rate Reconciliation, Tax Contingency, Amount Preclinical stage programs Preclinical Stage Programs [Member] Preclinical Stage Programs Purchase commitment, maximum amount committed Purchase Commitment, Maximum Amount Committed Purchase Commitment, Maximum Amount Committed Number of lowest sale prices Number Of Lowest Sale Prices Number Of Lowest Sale Prices Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name [Domain] Counterparty Name [Domain] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Two Stock split, conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Outstanding, ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Schedule of Accounts Payable and Accrued Expenses Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Health coverage to be received upon termination for cause or for good reason Employment Agreement, Health Benefits Coverage Received Upon Termination for Cause or Good Reason Employment Agreement, Health Benefits Coverage Received Upon Termination for Cause or Good Reason DARE-LARC1 DARE-LARC1 [Member] DARE-LARC1 Non-PEO NEO Non-PEO NEO [Member] Outstanding, ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Right-of-use assets Deferred Tax Liabilities, Leasing Arrangements Sale of Stock [Axis] Sale of Stock [Axis] Equity Award [Domain] Award Type [Domain] 2026 Lessee, Operating Lease, Liability, to be Paid, Year One Internal rate of return Royalty Agreement, Internal Rate Of Return Royalty Agreement, Internal Rate Of Return Equity Awards Adjustments Equity Awards Adjustments [Member] Leasehold improvements Leasehold Improvements [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Compensation Amount Outstanding Recovery Compensation Amount Preferred stock, initial stated value (in usd per share) Preferred Stock, Initial Stated Value Per Share Preferred Stock, Initial Stated Value Per Share Right-of-use asset - operating lease Increase (Decrease) In Operating Lease Right-of-Use Asset Increase (Decrease) In Operating Lease Right-of-Use Asset Convertible threshold trading days Preferred Stock, Convertible, Threshold Trading Days Preferred Stock, Convertible, Threshold Trading Days Regulation A Offering Regulation A Offering [Member] Regulation A Offering Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Estimate of Fair Value Measurement Estimate of Fair Value Measurement [Member] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Australia AUSTRALIA Consulting Agreement Consulting Agreement [Member] Consulting Agreement Revenue Revenue: Revenues [Abstract] Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Contra-R&D expenses Contra-R&D expenses Contra Research And Development Expense, Direct Program Costs Contra Research And Development Expense, Direct Program Costs Commitments and Contingencies Commitments Disclosure [Text Block] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Percentage of royalty rate Royalty Rate, Percentage Percentage of royalty rate. Total deferred tax liabilities Deferred Tax Liabilities, Gross Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Royalty Royalty [Member] Minimum Minimum [Member] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Payments on note payable Repayments of Notes Payable Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Company Selected Measure Name Company Selected Measure Name Fair Value Measurement [Domain] Fair Value Measurement [Domain] Insurance financing payable Insurance Financing Payable Insurance Financing Payable Placement fee Sale of Stock, Placement Fee, Percentage Sale of Stock, Placement Fee, Percentage Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Operating cash flows from operating leases Operating Lease, Payments Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Cash balance of financial institutions insured by federal deposits insurance corporation Cash, FDIC Insured Amount Maximum percentage increase License And Services Agreement, Maximum Fee Increase, Percentage License And Services Agreement, Maximum Fee Increase, Percentage Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Segment Information Segment Reporting, Policy [Policy Text Block] Share-based compensation arrangement, options, vested in period, fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Vendor One Major Vendor One [Member] Major Vendor One Entity Small Business Entity Small Business Payments of stock issuance costs Payments of Stock Issuance Costs Preferred stock, convertible, conversion price (in usd per share) Preferred Stock, Convertible, Conversion Price Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Document Transition Report Document Transition Report Square feet of office space Net Rentable Area Total lease payments Finance Lease, Liability, to be Paid Underlying Securities Award Underlying Securities Amount Equity Component Equity Component [Domain] Document Period End Date Document Period End Date Income Taxes Income Tax Disclosure [Text Block] Remaining obligation Contractual Obligation 2022 Stock Incentive Plan Two Thousand Twenty Two Stock Incentive Plan [Member] Two Thousand Twenty Two Stock Incentive Plan Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Option exercisable, ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Operating lease liability Increase (Decrease) in Operating Lease Liability Risks and Uncertainties [Abstract] Deferred grant funding Increase (Decrease) In Deferred Grant Funding Increase (Decrease) In Deferred Grant Funding Agent Common Warrant Agent Common Warrant [Member] Agent Common Warrant Document Type Document Type Quantity of Warrants Outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Level 3 Fair Value, Inputs, Level 3 [Member] Name Outstanding Recovery, Individual Name Monthly payments under consulting agreement Consulting Agreement, Monthly Payments Consulting Agreement, Monthly Payments Payments to stockholders' representative in business combination Payments to Stockholders' Representative in Business Combination Payments to Stockholders' Representative in Business Combination Product and Service [Axis] Product and Service [Axis] Business Combination, Contingent Consideration, Type [Domain] Business Combination, Contingent Consideration, Type [Domain] Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Options vested and expected to vest, ending (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Total current assets Assets, Current Statistical Measurement Statistical Measurement [Axis] Liability related to the sale of future royalties, net Royalty Guarantees, Commitments, Amount Issuance cost on equity line paid in common stock (in shares) Issuance Cost On Equity Line Paid In Common Stock, Shares Issuance Cost On Equity Line Paid In Common Stock, Shares Other receivables Other Receivables, Net, Current Issuance cost on equity line paid in common stock Issuance Cost On Equity Line Paid In Common Stock, Value Issuance Cost On Equity Line Paid In Common Stock, Value Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Change in control of company, termination for cause or for good reason Employment Agreement, Change in Control of Company, Termination for Cause or Good Reason Employment Agreement, Change in Control of Company, Termination for Cause or Good Reason Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Net loss to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Current Liabilities Liabilities, Current [Abstract] Research and development credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards, Research Total operating expenses Operating Expenses Lincoln Park Capital Fund, LLC Lincoln Park Capital Fund, LLC [Member] Lincoln Park Capital Fund, LLC Remeasurement of finance lease right-of-use assets and lease liabilities due to lease modification Finance Lease, Impairment Loss Level 1 Fair Value, Inputs, Level 1 [Member] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Royalty Revenue Royalty Revenue [Member] Royalty Revenue Accrued expenses Increase (Decrease) in Accrued Liabilities Loss per common share - diluted (in usd per share) Earnings Per Share, Diluted Total research and development indirect costs Research And Development Expense, Indirect Costs, Net Research And Development Expense, Indirect Costs, Net Proceeds from research and development arrangement with federal government Proceeds From Research and Development Arrangement with Federal Government Proceeds From Research and Development Arrangement with Federal Government Contingent purchase price payments Royalty Agreement, Contingent Purchase Price Payments Royalty Agreement, Contingent Purchase Price Payments Hard cap rate Royalty Agreement, Hard Cap, Percentage Royalty Agreement, Hard Cap, Percentage Sale of stock, number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Issuable upon additional investment made number of securities called by warrants Class Of Warrant Or Right, Initial Royalty Warrant Issued Class Of Warrant Or Right, Initial Royalty Warrant Issued Auditor Location Auditor Location Prepaid expenses Increase (Decrease) in Prepaid Expense Federal Domestic Tax Jurisdiction [Member] Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Permanent items Effective Income Tax Rate Reconciliation, Nondeductible Expense, Permanent Items, Percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Permanent Items, Percent Purchase And Registration Rights Agreement Purchase And Registration Rights Agreement [Member] Purchase And Registration Rights Agreement Less: amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Tax Credit Carryforward Tax Credit Carryforward [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Granted (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Accrued compensation and benefits Employee-related Liabilities, Current Property and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] Total lease payments Lessee, Operating Lease, Liability, to be Paid Audit Information [Abstract] Audit Information Expiration Date Trading Arrangement Expiration Date Other Commitments [Domain] Other Commitments [Domain] Upfront license fee paid Upfront License Fee, Amount Paid Upfront License Fee, Amount Paid Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Sale of royalty and milestone rights, net of transaction costs (Note 13) Sale of royalty and milestone rights, net Royalty Income, Nonoperating Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Amount due upon execution License And Services Agreement, Amount Payable Upon Execution License And Services Agreement, Amount Payable Upon Execution Accounts receivable Increase (Decrease) in Accounts Receivable Royalty agreement, repayment period Royalty Agreement, Additional Repayment Period Royalty Agreement, Additional Repayment Period Series A Preferred Stock Series A Preferred Stock [Member] Entity Current Reporting Status Entity Current Reporting Status Net royalty payments rate Royalty Agreement, Net Royalty Payments, Percentage Royalty Agreement, Net Royalty Payments, Percentage Receivables [Abstract] Receivables [Abstract] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Supplemental investment payment Royalty Agreement, Supplement Investment Payment Royalty Agreement, Supplement Investment Payment Income taxes (benefit) at statutory rates Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Executive Category: Executive Category [Axis] Stock compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent State income tax (benefit), net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Current portion of lease liabilities (finance) Finance Lease, Liability, Current Current Fiscal Year End Date Current Fiscal Year End Date Class of warrant or right, number of securities called by each warrant or right Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Grant Awards Grant Award [Text Block] Grant Award [Text Block] Expected life in years Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Strategic Agreements Collaborative Arrangement Disclosure [Text Block] Weighted-average fair value of options granted (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Effect of changes in tax laws or rates enacted in the current period State tax rate change Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Beginning balance uncertain tax benefits Ending balance of unrecognized tax benefits Unrecognized Tax Benefits Deferred issuance costs applied from prepayments made in the prior year Proceeds from Debt, Net of Issuance Costs Weighted average number of common shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Total accrued expenses Accounts Payable and Accrued Liabilities, Current Upon Achievement Of Specified Development And Regulatory Milestones Upon Achievement Of Specified Development And Regulatory Milestones [Member] Upon achievement of specified development and regulatory milestones. Leased Properties Lessee, Operating Leases [Text Block] Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Measure: Measure [Axis] Current portion of liability related to sale of future royalties Royalty Guarantees Commitments, Liability Related To Sale, Current Royalty Guarantees Commitments, Liability Related To Sale, Current Schedule of Warrant Activity Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Synthetic Synthetic [Member] Synthetic Initial payment Grants Receivable Grant funding recognized during period Grant Funding Recognized During Period Grant Funding Recognized During Period Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Non-cash royalty revenue related to sale of future royalties Non-Cash Lease Expense Non-Cash Lease Expense Entity Tax Identification Number Entity Tax Identification Number July 2024 Financing July 2024 Financing [Member] July 2024 Financing Outstanding beginning balance (in usd per share) Outstanding ending balance (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Common stock, shares issued (in shares) Common Stock, Shares, Issued Weighted-average remaining lease term, Operating leases (in years) Operating Lease, Weighted Average Remaining Lease Term Indirect cost allowance percentage Grant Awards, Indirect Cost Allowance, Percentage Grant Awards, Indirect Cost Allowance, Percentage Entity Public Float Entity Public Float Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Indemnification Obligations Guarantees, Indemnifications and Warranties Policies [Policy Text Block] Reportable Segment Reportable Segment [Member] Reportable Segment Issuance cost on equity paid in common stock Capital Expenditures Incurred but Not yet Paid ADVA Tec Agreement A D V A Tec Agreement [Member] ADVA Tec agreement. Douglas License Agreement Douglas License Agreement [Member] Douglas License Agreement Operating expenses Segment operating expenses: Operating Expenses [Abstract] Prepaid expenses and other current assets Total prepaid expenses and other current assets Prepaid Expense, Current Effective annual interest rate Royalty Agreement, Effective Annual Interest Rate, Percentage Royalty Agreement, Effective Annual Interest Rate, Percentage Statement [Line Items] Statement [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalent Subsequent Event [Line Items] Subsequent Event [Line Items] Research Credit Carryforwards Research Tax Credit Carryforward [Member] Common stock Common Stock [Member] Finance Lease Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Net change in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Research and Development Arrangement, Contract to Perform for Others, Type Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Less: amount representing interest Operating And Finance Lease Liability, Undiscounted Excess Amount Operating And Finance Lease Liability, Undiscounted Excess Amount July 2025 Financing July 2025 Financing [Member] July 2025 Financing Statistical Measurement Statistical Measurement [Domain] Related Party Transaction Related Party Transaction [Axis] Payments of deferred offering costs Payments of Financing Costs Leases [Abstract] Leases [Abstract] Additions related to prior year positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Accounts payable Increase (Decrease) in Accounts Payable Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Warrants outstanding (in shares) Class of Warrant or Right, Outstanding Loss per common share - basic (in usd per share) Earnings Per Share, Basic License And Collaboration Agreement License And Collaboration Agreement [Member] License And Collaboration Agreement [Member] Common stock reserved for issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Changes in unrecognized tax benefits Effective Income Tax Rate Reconciliation, Tax Contingency, Percent Total deferred tax assets Deferred Tax Assets, Gross Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Prepaid development expense Prepaid Development Expense, Current Prepaid Development Expense, Current March 2023 At The Market Sales Agreement March 2023 At The Market Sales Agreement [Member] March 2023 At The Market Sales Agreement Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Trigger price during public offering (in usd per share) Preferred Stock, Convertible, Public Offering, Share Price Trigger Preferred Stock, Convertible, Public Offering, Share Price Trigger Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Accounts and Financing Receivables [Table] Stock-based compensation expense Share-Based Payment Arrangement, Expense Current Assets Assets, Current [Abstract] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities and stockholders' equity (deficit) Liabilities and Equity Contra R&D expenses Contra Research And Development Expense, Indirect Costs Contra Research And Development Expense, Indirect Costs Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Licensing Agreements Licensing Agreements [Member] Other Deferred Tax Assets, Other Selling, general and administrative General and Administrative Expense [Member] Accounting Policies [Abstract] Accounting Policies [Abstract] Reverse stock split adjustment Stock Issued During Period, Value, Reverse Stock Splits Stock Issued During Period, Value, Reverse Stock Splits Schedule of Operating Lease Liabilities Maturity Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Pay vs Performance Disclosure [Line Items] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Present value of lease liabilities Operating Lease, Liability Preferred stock, liquidation preference per share (in usd per share) Preferred Stock, Liquidation Preference Per Share Amortization of finance lease Finance Lease, Right-of-Use Asset, Amortization Deferred revenue Increase (Decrease) in Deferred Revenue Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Expired (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Name Measure Name License and services agreement term License And Services Agreement, Term License And Services Agreement, Term Class of Stock [Line Items] Class of Stock [Line Items] Legal Entity [Axis] Legal Entity [Axis] Total assets Assets Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract] Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] National Collegiate Inventors And Innovators Alliance, Inc. d/b/a VentureWell CMF National Collegiate Inventors And Innovators Alliance, Inc. d/b/a VentureWell [Member] National Collegiate Inventors And Innovators Alliance, Inc. d/b/a VentureWell Income Taxes Income Tax, Policy [Policy Text Block] Basis of Presentation and Summary of Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Research and development credit Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Additional investment amount Class Of Warrant Or Right, Supplement Investment Class Of Warrant Or Right, Supplement Investment Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total research and development direct program costs Research And Development Expense, Direct Program Costs, Net Research And Development Expense, Direct Program Costs, Net Upon Achieving Certain Commercial Milestones Upon Achieving Certain Commercial Milestones [Member] Upon Achieving Certain Commercial Milestones [Member] Biotherapeutic Product Grant Agreement Biotherapeutic Product Grant Agreement [Member] Biotherapeutic Product Grant Agreement Basis after conversion (in shares) Stockholders' Equity Note, Stock Split, Conversion Basis After Reverse Stock Split Stockholders' Equity Note, Stock Split, Conversion Basis After Reverse Stock Split Aggregate commission rate Percentage Of Aggregate Commission Percentage of aggregate commission. 2026 Finance Lease, Liability, to be Paid, Year One Warrant Warrant [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Remeasurement of operating lease right-of-use assets and lease liabilities due to lease modification Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Level 2 Fair Value, Inputs, Level 2 [Member] Document Financial Statement Error Correction [Flag] Document Financial Statement Error Correction [Flag] State income tax (benefit), net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Business Combination [Domain] Business Combination [Domain] Accrued development expense Accrued Development Expense, Current Accrued Development Expense, Current Operating Leases Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Related Party Related Party [Member] Lab equipment Lab Equipment [Member] Lab Equipment Summary of Components of Loss from Continuing Operations Before Provision for Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Plan Name [Axis] Plan Name [Axis] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] PEO PEO [Member] Lease Contractual Term [Domain] Lease Contractual Term [Domain] Royalty Purchase Agreement Royalty Purchase Agreement [Member] Royalty Purchase Agreement Interest income Investment Income, Interest United States UNITED STATES Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Accumulated Deficit Retained Earnings [Member] Income Tax Jurisdiction [Axis] Income Tax Jurisdiction [Axis] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash, cash equivalents and restricted cash, beginning of year Cash, cash equivalents and restricted cash, end of year Total cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Sales based milestones amount Milestone Payments, Contingent Amount, Sales Based Milestones Amount Milestone Payments, Contingent Amount, Sales Based Milestones Amount Sale of Stock [Domain] Sale of Stock [Domain] September 2023 Warrants September 2023 Warrants [Member] September 2023 Warrants Permanent items Effective Income Tax Rate Reconciliation, Nondeductible Expense, Permanent Items, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Permanent Items, Amount Interest payable Increase (Decrease) in Interest Payable, Net Product and Service [Domain] Product and Service [Domain] Bayer Bayer Healthcare LLC [Member] Bayer Healthcare LLC Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Cash paid for amounts included in the measurement of lease liabilities Cash Flow, Operating Activities, Lessee [Abstract] City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Vendor Four Major Vendor Four [Member] Major Vendor Four Agent Unit Warrants Agent Unit Warrants [Member] Agent Unit Warrants Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Liability related to the sale of future royalties Royalty Guarantees, Commitments, Gross Amount Royalty Guarantees, Commitments, Gross Amount IT equipment Technology Equipment [Member] Related Party Transactions [Abstract] Total lease cost Lease, Cost Effective Income Tax Rate Reconciliation [Line Items] Effective Income Tax Rate Reconciliation [Line Items] Schedule of Lease Cost Lease, Cost [Table Text Block] Lease Contractual Term [Axis] Lease Contractual Term [Axis] Unrecognized Tax Benefits [Roll Forward] Unrecognized Tax Benefits [Roll Forward] Auditor Name Auditor Name Former Stockholders of MBI Former Stockholders of MBI [Member] Former Stockholders of MBI Sildenafil Cream, 2.0% Sildenafil Cream, 2.0% [Member] Sildenafil Cream, 2.0% Concentration Risk [Table] Concentration Risk [Table] Basis prior to conversion (in shares) Stockholders' Equity Note, Stock Split, Conversion Basis Prior To Reverse Stock Split Stockholders' Equity Note, Stock Split, Conversion Basis Prior To Reverse Stock Split Commitments And Contingencies [Table] Commitments And Contingencies [Table] Commitments and contingencies. Warrant term Warrants and Rights Outstanding, Term Supplemental disclosure of non-cash investing and financing activities: Supplemental Cash Flow Information [Abstract] Premiums, taxes and fees Insurance Financing, Premiums, Taxes And Fees, Amount Insurance Financing, Premiums, Taxes And Fees, Amount Other Performance Measure, Amount Other Performance Measure, Amount Weighted- Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Issuance costs Payments of Debt Issuance Costs DARE-HPV DARE-HPV [Member] DARE-HPV Related Party [Domain] Related and Nonrelated Parties [Domain] Amount Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Working capital Working Capital Increase (Deficit) Working Capital Increase (Deficit) Leased Properties Lessee, Finance Leases [Text Block] Future net sales Royalty Agreement, Future Net Sales, Percentage Royalty Agreement, Future Net Sales, Percentage Additional paid-in capital Additional Paid in Capital, Common Stock Entity [Domain] Entity [Domain] Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Royalty Purchase Agreements Royalty Purchase Agreements [Text Block] Royalty Purchase Agreements Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Reimburse amount, PDUFA fees and other manufacturing expenses Milestone Payments, Reimburse Amount, PDUFA Fees and Other Manufacturing Expenses Milestone Payments, Reimburse Amount, PDUFA Fees and Other Manufacturing Expenses Operating lease cost Operating Lease, Cost Decreases related to prior year positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Continuing Operation [Abstract] Plan Name [Domain] Plan Name [Domain] Expiration of attributes Effective Income Tax Rate Reconciliation, Expiration Of Attributes, Amount Effective Income Tax Rate Reconciliation, Expiration Of Attributes, Amount Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Valuation allowance Deferred tax valuation allowance Deferred Tax Assets, Valuation Allowance Equity [Abstract] Equity [Abstract] Segment Information Segment Reporting Disclosure [Text Block] Schedule Of Supplemental Cash Flows Information Related To Leases Schedule Of Supplemental Cash Flows Information Related To Leases [Table Text Block] Schedule Of Supplemental Cash Flows Information Related To Leases XOMA XOMA (US) LLC [Member] XOMA (US) LLC Performance period Research And Development Arrangement, Performance Period Research And Development Arrangement, Performance Period Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Leases Lessee, Leases [Policy Text Block] Selling, general and administrative Selling, general and administrative Selling, General and Administrative Expense 2026 Operating And Finance Lease Liability Payments Due Year One Operating And Finance Lease Liability Payments Due Year One Accrued license fee expense Accrued License Expense, Current Accrued License Expense, Current Depreciation and amortization Depreciation, Depletion and Amortization Health coverage to be received upon termination without cause Employment Agreement, Health Benefits Coverage Received Upon Termination Without Cause Employment Agreement, Health Benefits Coverage Received Upon Termination Without Cause Net proceeds from sale of stock offering Sale of Stock, Consideration Received on Transaction Change in control of company, termination without cause or resignation for good reason, period Employment Agreement, Change In Control Of Company, Termination Without Cause Or Resignation For Good Reason Employment Agreement, Change In Control Of Company, Termination Without Cause Or Resignation For Good Reason, Period Present value of lease liabilities Finance Lease, Liability Arrangement Duration Trading Arrangement Duration Segments [Axis] Segments [Axis] Maximum royalty payments Royalty Agreement, Maximum Royalty Payments Royalty Agreement, Maximum Royalty Payments Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Company's common stock price (in usd per share) Share Price Capitalized research and development costs Deferred Tax Assets Capitalized Research And Development Cost Deferred Tax Assets Capitalized Research And Development Cost Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Assets Assets [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Other Commitments [Axis] Other Commitments [Axis] Debt Instrument [Axis] Debt Instrument [Axis] Stockholders' equity (deficit) Equity, Attributable to Parent [Abstract] October 2016 Warrants October 2016 Warrants [Member] October 2016 Warrants Assignment Agreement Assignment Agreement [Member] Assignment Agreement [Member] Prepaid legal and professional expenses Prepaid Professional Expense, Current Prepaid Professional Expense, Current Lease liabilities long term (operating) Operating Lease, Liability, Noncurrent Entity Voluntary Filers Entity Voluntary Filers Significant Accounting Policies [Table] Significant Accounting Policies [Table] Significant accounting policies. Property, Plant and Equipment [Abstract] Entity Registrant Name Entity Registrant Name Collaborative Arrangement Collaborative Arrangement [Member] Other non-current assets Increase (Decrease) in Other Noncurrent Assets Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Receivable for expenses eligible for reimbursement Receivable For Expenses Eligible For Reimbursement Receivable For Expenses Eligible For Reimbursement Revenue from contract with customer termination of contract Revenue From Contract With Customer, Termination Of Contract Revenue From Contract With Customer, Termination Of Contract Present value of lease liabilities Operating And Finance Lease Liability Operating And Finance Lease Liability Number of operating segments Number of Operating Segments Sildenafil Cream, 3.6% Sildenafil Cream, 3.6% [Member] Sildenafil Cream, 3.6% Quarterly payment period Royalty Agreement, Quarterly Payments, Period Royalty Agreement, Quarterly Payments, Period Related Party [Axis] Related and Nonrelated Parties [Axis] Cash flow from operations Cash Provided by (Used in) Operating Activity, Continuing Operation Clinical And Regulatory Milestones Clinical And Regulatory Milestones [Member] Clinical And Regulatory Milestones [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Restatement Determination Date: Restatement Determination Date [Axis] Exercise of Options Outstanding Exercise Of Options Outstanding [Member] Exercise of options outstanding. Australian Taxation Office Australian Taxation Office [Member] Expiration of attributes Effective Income Tax Rate Reconciliation, Expiration Of Attributes, Percent Effective Income Tax Rate Reconciliation, Expiration Of Attributes, Percent Effect of changes in tax laws or rates enacted in the current period Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Name Trading Arrangement, Individual Name Operating lease, incremental borrowing rate, prime rate Operating Lease, Incremental Borrowing Rate, Prime Rate Operating Lease, Incremental Borrowing Rate, Prime Rate Upon Reaching Certain Worldwide Net Sales Milestones Upon Reaching Certain Worldwide Net Sales Milestones [Member] Upon reaching certain worldwide net sales milestones. United United in Endeavor, LLC [Member] United in Endeavor, LLC Name Awards Close in Time to MNPI Disclosures, Individual Name Upon Achieving Certain Development Milestones Upon Achieving Certain Development Milestones [Member] Upon Achieving Certain Development Milestones [Member] Warrants outstanding (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Other cost Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Defined contribution plan, employer matching contribution, percent of match Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Maximum potential milestone payments Maximum Potential Milestone Payments Maximum Potential Milestone Payments Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Schedule of Finance Lease Liabilities Maturity Finance Lease, Liability, to be Paid, Maturity [Table Text Block] Options vested and expected to vest, ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Foreign tax effects Foreign Tax Jurisdiction [Member] Auditor Firm ID Auditor Firm ID Gross proceeds from trigger Preferred Stock, Convertible, Public Offering Proceeds, Trigger Preferred Stock, Convertible, Public Offering Proceeds, Trigger Segments [Domain] Segments [Domain] Phase II Segment Phase II Segment [Member] Phase II Segment Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Axis] MBI MBI [Member] MBI Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Catalent and MilanaPharm Catalent and MilanaPharm [Member] Catalent and MilanaPharm Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Variable lease cost Variable Lease, Payment Potential annual license maintenance fee payments, thereafter Potential Annual License Maintenance Fee Payments, Thereafter Potential Annual License Maintenance Fee Payments, Thereafter Class of warrant or right, number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Less– accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Preferred stock, $0.01 par value, 5,000,000 shares authorized; None issued and outstanding Preferred Stock, Value, Issued Credits recorded to research and development expense for costs related to award Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred All Executive Categories All Executive Categories [Member] Summary of Major Components of Company's Deferred Tax Assets Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Common stock, $0.0001 par value, 240,000,000 shares authorized, 14,499,502 and 8,700,386 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively Common Stock, Value, Issued Finance lease right-of-use assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Commitments and contingencies (Note 14) Commitments and Contingencies Potential future payment Royalty Agreement, Maximum Potential Milestone Payments Royalty Agreement, Maximum Potential Milestone Payments Licensed Product or Process for Vaginal or Urological Use Licensed Product or Process for Vaginal or Urological Use [Member] Licensed Product or Process for Vaginal or Urological Use Business Combination [Axis] Business Combination [Axis] Concentration Risk [Line Items] Concentration Risk [Line Items] Net deferred tax assets (liabilities) Deferred Tax Assets, Net License And Collaboration Revenues License And Collaboration Revenues [Member] License And Collaboration Revenues Project [Axis] Project [Axis] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Non-cash interest expense Non-Cash Interest Expense Non-Cash Interest Expense Juniper Pharmaceuticals, Inc. Juniper Pharmaceuticals, Inc. [Member] Juniper Pharmaceuticals, Inc. [Member] Potential future payment, percentage Royalty Agreement, Milestone Payments, Sales Based Potential Future Milestones Royalty Agreement, Milestone Payments, Sales Based Potential Future Milestones Number of proceeding business period Number Of Proceeding Business Period Number Of Proceeding Business Period Royalty agreement, estimated amount of royalty obligation Royalty Agreement, Estimated Amount Of Royalty Obligation Royalty Agreement, Estimated Amount Of Royalty Obligation Schedule of Reconciliation of the Beginning and Ending Amount of Uncertain Tax Benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Net proceeds from issuance of common stock Proceeds from Issuance of Common Stock Revenue tier threshold, upper range limit Royalty Agreement, Revenue Tier Threshold, Incremental Amount Royalty Agreement, Revenue Tier Threshold, Incremental Amount All Individuals All Individuals [Member] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Name Forgone Recovery, Individual Name Risks and Uncertainties Risks And Uncertainties [Policy Text Block] Risks and uncertainties Expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Net operating loss carryforwards expiration year Operating Loss Carryforwards Expiration Period Operating loss carryforwards expiration period. Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Asset acquisition, contingent consideration, current Asset Acquisition, Contingent Consideration, Current Asset Acquisition, Contingent Consideration, Current Reconciliation of cash, cash equivalents and restricted cash to amounts reported in the consolidated balance sheets: Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] Issuance of note payable Proceeds from Notes Payable Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Total Operating And Finance Lease, Liability [Abstract] Operating And Finance Lease, Liability Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Offering expenses, net Offering Cost, Expense Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Title of 12(b) Security Title of 12(b) Security Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Prepaid insurance expense Prepaid Insurance Warrants or rights, exercised (as percent) Class of Warrant or Right, Percentage Common Stock Ownership After Exercise Class of Warrant or Right, Percentage Common Stock Ownership After Exercise Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Contraceptive Product Grant Agreement Contraceptive Product Grant Agreement [Member] Contraceptive Product Grant Agreement Milestone payments rate Royalty Agreement, Milestone Payments, Percentage Royalty Agreement, Milestone Payments, Percentage Clean Room Space Clean Room Space [Member] Clean Room Space Research credit carryforwards Tax Credit Carryforward, Amount Aggregate Intrinsic Value * Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Aggregate Intrinsic Value Roll Forward Share based compensation arrangement by share based payment award options outstanding aggregate intrinsic value. Assets under construction Asset under Construction [Member] Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities [Member] Direct program costs: Research And Development Expense, Direct Program Costs Research And Development Expense, Direct Program Costs DARE-LBT DARE-LBT [Member] DARE-LBT Research credit carryforwards expiration year Tax Credit Carryforward Expiration Period Tax credit carry forward expiration period. Deferred offering costs Deferred Offering Costs Exercised (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Registration statement period Sale Of Stock, Registration Statement Period Sale Of Stock, Registration Statement Period Award Timing Disclosures [Line Items] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Renewal term of operating lease Lessee, Operating Lease, Renewal Term Stockholders' Equity Equity [Text Block] Ovaprene Ovaprene [Member] Ovaprene Warrants purchased on units sold Preferred Stock, Percentage Of Stated Value Per Share Preferred Stock, Percentage Of Stated Value Per Share Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Subsequent Event [Table] Subsequent Event [Table] Other accruals Other Accrued Liabilities, Current Difference Between Provision (Benefit) for Income Taxes and the Amount Computed by Applying U.S. Federal Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Prepaid Expenses and Other Current Assets Other Current Assets [Text Block] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Adoption Date Trading Arrangement Adoption Date Reclassification of Prior Year Presentation Reclassification, Comparability Adjustment [Policy Text Block] Prepaid rent reclassified to finance lease right-of-use asset Prepaid Rent Reclassified To Finance Lease Right Of Use Asset Prepaid Rent Reclassified To Finance Lease Right Of Use Asset Shares issued, price per share (in usd per share) Shares Issued, Price Per Share Operating lease, term of contract (in years) Lessee, Operating Lease, Term of Contract Customer [Axis] Customer [Axis] Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract] Loss from operations Loss from operations Operating Income (Loss) Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Supplier Concentration Risk Supplier Concentration Risk [Member] Grant, DARE-PTB2 Grant, DARE-PTB2 [Member] Grant, DARE-PTB2 Unamortized stock-based compensation expense Deferred Compensation Share-Based Arrangements, Liability, Current and Noncurrent Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Class of Stock [Axis] Class of Stock [Axis] Hennepin License Agreement Hennepin License Agreement [Member] Hennepin License Agreement Officers' compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Executive Bonus Plan, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Officers Compensation, Amount NICHD NICHD [Member] NICHD Subsequent Event Type [Domain] Subsequent Event Type [Domain] Milestone payments, contingent amount, first commercial sale amount Milestone Payments, Contingent Amount, First Commercial Sale Amount Milestone Payments, Contingent Amount, First Commercial Sale Amount Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Other Deferred Tax Liabilities, Other Payables and Accruals [Abstract] Payables and Accruals [Abstract] Other income (expense) Other income (expense) Other income (expense), net Other Nonoperating Income (Expense) Statement [Table] Statement [Table] Adjustments to reconcile net loss to net cash (used in) provided by operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Decreases as a result of a lapse of the applicable statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Research and development credit Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent Organization and Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Prepaid clinical expense Prepaid Clinical Expense, Current Prepaid Clinical Expense, Current All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Sale of stock, price per share Sale of Stock, Price Per Share Options to purchase number of outstanding shares of common stock (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Phase 1 and Phase 1-ready clinical stage programs Phase 1 And Phase 1-Ready Clinical Stage Programs [Member] Phase 1 And Phase 1-Ready Clinical Stage Programs Termination Date Trading Arrangement Termination Date Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Federal Subaward Federal Subaward [Member] Federal Subaward Weighted-average discount rate, Operating leases Operating Lease, Weighted Average Discount Rate, Percent Schedule of Stock Option Activity for 2015 Plan and Current Plan and Related Information Share-Based Payment Arrangement, Option, Activity [Table Text Block] Accrued interest or penalties recorded related to uncertain tax positions Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Schedule of Financial Assets and Liabilities Remeasured on a Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Basic (in shares) Weighted Average Number of Shares Outstanding, Basic XACIATO XACIATO [Member] XACIATO Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Unrecognized tax benefits, net Unrecognized Tax Benefits that Would Impact Effective Tax Rate Warrants and rights outstanding (in shares) Relative fair value of Initial Royalty Warrant Warrants and Rights Outstanding Restricted cash included in other non-current assets Restricted Cash and Cash Equivalent, Noncurrent Options exercisable, ending (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Related Party Transaction Related Party Transaction [Domain] Subsequent Events [Abstract] Subsequent Events [Abstract] Segment Reporting [Abstract] Non-compounded rate of return Preferred Stock, Non-Compounded Rate Of Return, Percentage Preferred Stock, Non-Compounded Rate Of Return, Percentage Cost of revenues Cost of Revenue Schedule of Weighted Average Remaining Lease Terms and Discount Rates Weighted Average Remaining Lease Terms And Discount Rates [Table Text Block] Weighted Average Remaining Lease Terms And Discount Rates Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Term of related party agreement Related Party Transaction, Term Related Party Transaction, Term Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in usd per share) Common Stock, Par or Stated Value Per Share Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Use of Estimates Use of Estimates, Policy [Policy Text Block] Interest on finance lease liability Operating cash flows from finance lease Finance Lease, Interest Payment on Liability Schedule of Common Stock Reserved for Future Issuance Schedule Of Common Stock Reserved For Future Issuance [Table Text Block] Schedule of common stock reserved for future issuance Subsequent Events Subsequent Events [Text Block] Deposits Increase (Decrease) in Deposit Assets Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Insider Trading Arrangements [Line Items] Forfeited (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Total liabilities Liabilities Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Additions related to current year positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Investor Warrants Investor Warrants [Member] Investor Warrants Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Operating loss carryforwards not subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Indirect costs: Research And Development Indirect Costs [Abstract] Research And Development Indirect Costs Percentage of warrants issuable Sale Of Stock, Percentage Of Warrants Issuable Sale Of Stock, Percentage Of Warrants Issuable Issuance of common stock, net of issuance costs Stock Issued During Period, Value, New Issues Counterparty Name [Axis] Counterparty Name [Axis] Shares available not to issue or sell more than (in shares) Sale of Stock, Shares Available Not To Issue Or Sell Sale of Stock, Shares Available not to Issue or Sell Organon Organon [Member] Organon Tax Credit Carryforward, Name Tax Credit Carryforward, Name [Domain] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Payment of additional consideration in business combination Payment of Additional Consideration in Business Combination Payment of Additional Consideration in Business Combination